NexPoint Real Estate Finance, Inc.’s 2025 Q4 Call: Life Science Leasing Outlook, Multifamily Growth Timing, Credit Loss Allocation Contradict Prior Guidance

Date of Call: Feb 26, 2026

Financials Results

• EPS: $0.52 per diluted share, up from $0.43 in Q4 '24

Guidance:

• Earnings available for distribution (EAD) for Q1 2026 expected to be $0.40 per diluted share at the midpoint, with a range of $0.35 to $0.45.
• Cash available for distribution (CAD) for Q1 2026 expected to be $0.50 per diluted share at the midpoint, with a range of $0.45 to $0.55.

Business Commentary:

Earnings and Dividend Sustainability:

• NexPoint Real Estate Finance, Inc. reported net income of $0.52 per diluted share for Q4 2025, compared to $0.43 in Q4 2024, with an increase driven by unrealized gains on preferred stock and stock warrant investments.
• Earnings available for distribution were $0.48 per diluted share, down from $0.83 in Q4 2024, while cash available for distribution was $0.53 per diluted share, up from $0.47 in the prior quarter.
• The company's ability to maintain its $0.50 dividend per share was supported by strong cash available for distribution and strategic financial moves like the re-REMIC transaction and Series C preferred stock raises.

Portfolio Performance and Market Positioning:

• The company's portfolio consists of 92 investments with a total outstanding balance of $1.2 billion, predominantly in multifamily, Life Sciences, and single-family rental sectors.
• The portfolio's strong performance was attributed to intentional asset selection in recession-resilient property types, such as residential and self-storage, and a strategic focus on Life Sciences, benefiting from AI-related demand and limited new supply.

Life Sciences Exposure and AI Demand:

• The largest single asset exposure in Life Sciences, Alewife Park, is now 64% leased, with significant demand driven by tenants requiring purpose-built infrastructure.
• The leasing momentum has increased due to the project's location, infrastructure capabilities, and the broader trend of AI companies needing specialized buildings, positioning it for full leasing in 2026.

Self-Storage and Residential Market Trends:

• The self-storage sector saw 91.7% occupancy for NexPoint's portfolio in 2025, outperforming the industry with a 13% NOI growth.
• Despite industry-wide occupancy pressure, NexPoint's portfolio benefited from constrained supply and rising move-in rates, with expectations for moderated NOI growth in 2026.

Debt Management and Refinancing Strategy:

• NexPoint refinanced $36.5 million of unsecured notes with a new $45 million offering at 7.875%, improving its debt-to-equity ratio.
• The refinancing efforts and strategic debt management are part of a broader plan to position the company well in the current interest rate environment and enhance capital efficiency.

Sentiment Analysis:

Overall Tone: Positive

• Management expressed strong confidence in dividend sustainability and portfolio performance. Paul Richards stated, 'We feel very good on the go forward... we feel well positioned for the future.' Matthew McGraner said, 'I'm very pleased with our pipeline and menu of capital options available to us... you can expect that we will also continue to opportunistically buy back stock.'

Q&A:

• Question from Benjamin Graham (Piper Sandler & Co.): Can you guys hear me all right?
  Response: Confirmed hearing.

• Question from Benjamin Graham (Piper Sandler & Co.): I'm wondering if you could discuss dividend sustainability and your confidence in the current level... And when do you believe you could be covering the dividend on a more consistent basis with EAD?
  Response: The Board believes CAD, not EAD, is the better indicator of dividend coverage and sustainability, and they have consistently approved the $0.50 dividend. Future support is expected from the re-REMIC transaction and Series C preferred stock raises.

• Question from Benjamin Graham (Piper Sandler & Co.): When you look at your portfolio areas... I'm wondering what areas you're most excited about today? And then further, how do you expect the administration's focus on real estate mortgage and single-family affordability to impact some of the areas where you're invested?
  Response: Most excited about BTR and multifamily new construction deals. On regulation, they think the opportunity remains for BTR assets, and if regulations impact scattered-site SFR, it could create an opportunity for them to provide capital in that space.

• Question from Jade Rahmani (Keefe, Bruyette, & Woods, Inc.): Can you touch on the provision for credit loss that took place in the quarter, around $12 million and what you expect on that going forward?
  Response: The provision was $12M, with one-third for general reserve updates and two-thirds related to specific pref deals. Expectations are for it to level off in 2026 as there are no significant new problem areas.

• Question from Jade Rahmani (Keefe, Bruyette, & Woods, Inc.): And just on the Life Science project... Could you give your thoughts as to what the project-specific characteristics are that drove the positive performance? And if you're seeing outside of this project, any uptick in Life Science leasing activity that might make you look at other deals in that sector?
  Response: Alewife Park's positive performance is due to its purpose-built, slab-on-grade design in a prime West Cambridge location and a cluster effect from initial tenants. More broadly, they are seeing increased optimism and leasing activity across the Life Science portfolio, driven in part by AI demand.

• Question from Gabriel Poggi (Raymond James & Associates, Inc.): Can you give a little more details around the loans you made in the quarter, specifically the $22.5 million loan, 11%...?
  Response: Loans included a continued commitment on the Alewife project (SOFR + 900 bps), two marina loans totaling ~$17.4M at 13%, and a self-storage deal at 13%. The approach is to find sound, cash-flow positive deals using a 'rifle-shot' strategy.

• Question from Gabriel Poggi (Raymond James & Associates, Inc.): ...Can you talk about how big that sandbox could be for you guys as you just think about the whole... what NexPoint holistically looks at...
  Response: The BTR opportunity set is significant, with ~$550M under contract and a steady pipeline of ~$200M in new construction reviewed monthly. They focus on smaller, community-adjacent projects (50-150 units) and are open to financing across the cap stack.

Contradiction Point 1

Outlook on Life Science Leasing Activity

Contradiction on the sector's leasing momentum and investment appeal.

Jade Rahmani (Keefe, Bruyette, & Woods, Inc.) - Jade Rahmani (Keefe, Bruyette, & Woods, Inc.)

2025Q4: More broadly, there is growing optimism and capital activity in Life Sciences in the last 30-60 days. The demand funnel is widening... The company sees strong tailwinds for this sector. - Matthew McGraner(EVP & CIO)

Regarding the Life Science project (Alewife Park) that has bucked the industry trend, what project-specific characteristics drove its positive leasing performance, and are you seeing an uptick in Life Science leasing activity that would lead you to consider other deals in the sector? - Jason Sabshon (Keefe, Bruyette, & Woods, Inc., Research Division)

2025Q3: The good news about our life sciences book is we didn't start making life science loans until 2024... This lease, which is the first of many green shoots, allows us to potentially A note the loan, refi it, or sell it given its attractive terms. - Matthew McGraner(EVP & CIO)

Contradiction Point 2

Expected Timing for New Lease Growth in Multifamily

Contradiction on when new lease growth will inflect in Sunbelt markets.

Can you provide an update on the company's recent financial performance? - Benjamin Graham (Piper Sandler & Co.)

2025Q4: The team is currently spending the most time on build-to-rent (BTR) and multifamily new construction... They feel good about BTR assets as they add to housing stock. - Matthew McGraner(EVP & CIO)

How do you expect the administration's focus on real estate mortgage and single-family affordability to impact your prioritization of portfolio areas like multifamily, single-family rental, self-storage, and Life Sciences? - Jason Sabshon (Keefe, Bruyette, & Woods, Inc., Research Division)

2025Q3: New lease growth is beginning to inflect in key constrained markets like San Francisco and New York, and is expected to reach the Sunbelt market in Q2/Q3 2026. - Matthew McGraner(EVP & CIO)

Contradiction Point 3

Credit Loss Provision Allocation

Contradiction on the primary cause of the credit loss provision increase.

Jade Rahmani (Keefe, Bruyette, & Woods, Inc.) - Jade Rahmani (Keefe, Bruyette, & Woods, Inc.)

2025Q4: About one-third of the provision was for the general reserve, updated to be more conservative... The remaining two-thirds were related to specific deals (mainly preferred equity)... - Paul Richards(CFO)

Could you discuss the $12 million provision for credit loss in the quarter and your expectations moving forward? - Jade Rahmani (KBW)

2025Q1: The increased CECL reserve was due to a weighted average base case and downside scenario and a proactive reserve for a specific private preferred... The CECL reserve increase was about 50-50 split between the weighted average base case/downside scenario and the specific private preferred. - Paul Richards(CFO)